DAVID PENDARVIS - 03 Jun 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Administrative Officer
Signature
David Pendarvis, Chief Administrative Officer
Issuer symbol
RMD
Transactions as of
03 Jun 2021
Net transactions value
-$307,809
Form type
4
Filing time
07 Jun 2021, 13:10:16 UTC
Next filing
07 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale $307,809 -1,487 -1.2% $207.00 126,387 03 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Includes 66.72 shares of ResMed stock purchased on April 30, 2021, through the ResMed Employee Stock Purchase Plan.